About The ASCO Post
Rights and Permissions
In the Clinic
View By Issue
ESMO 2019 Congress
NCCN 2019 Annual Congress: Hematologic Malignancies
2019 Supportive Care in Oncology Symposium
2019 NCRI Cancer Conference
2019 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Biomarkers in Immunotherapy
IMPROVING NSCLC OUTCOMES
Methotrexate–Induced Kidney Injury
No results found for "Andrew J. Armstrong, MD, ScM"
Ensure words are spelled correctly.
Try rephrasing keywords or using synonyms.
Try less specific keywords.
Today In Oncology
Bendamustine/Rituximab Followed by Y-90 Ibritumomab Tiuxetan in Previously Untreated Follicular Lymphoma
Study Finds Nearly One in Four Oncologists Rarely or Never Mention Cost When Discussing Genomic Testing
Levofloxacin Prophylaxis During Treatment of Newly Diagnosed Multiple Myeloma
PROs Observed With Durvalumab Treatment After Chemoradiotherapy for Stage III Unresectable NSCLC
Factors Influencing Freedom From Distant Recurrence in Premenopausal Women With HR-Positive, HER2-Negative Breast Cancer
Most Read Stories
Management of Locally Advanced Pancreatic Cancer: A Call for Action
Veliparib Plus Chemotherapy Meets Primary Endpoint in Advanced Ovarian Cancer
Outcomes in Patients With Early Breast Cancer and High 21-Gene Recurrence Score Treated With Adjuvant Chemotherapy Plus Endocrine Therapy: Secondary Analysis of TAILORx
PAOLA-1 Trial: Front-Line Olaparib/Bevacizumab Maintenance Benefits Women With Advanced Ovarian Cancer
Third-Line Cabazitaxel Improves Outcomes in Patients With Metastatic Prostate Cancer
© 2019 HSP News Service, L.L.C.